Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Tumour Biol ; 35(10): 10409-18, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25053599

ABSTRACT

This study aims to evaluate the risk and benefit profiles of panitumumab-based therapy (PBT) in patients with metastatic colorectal cancer (mCRC). Relevant randomized controlled trials were identified by searching PubMed, Medline, EMBASE and Cochrane Library. Data on progression-free survival (PFS), overall survival (OS), all grade and severe (grade ≥3) adverse events were extracted and pooled to calculate hazard ratios (HRs) and risk ratios (RRs) with 95 % confidence intervals (CIs). Number needed to treat (NNT) for PFS and number needed to harm (NNH) for significantly changed toxicities were calculated. A total of 4,155 patients were included in the analysis. PBT significantly improved PFS (HRrandom = 0.66, 95 % CI = 0.45-0.95) but not OS (HRfixed = 0.93, 95 % CI = 0.83-1.04) when used in the subsequent-line setting. The effect on PFS was more evident in patients with wild-type KRAS (HRrandom = 0.64, 95 % CI = 0.47-0.87) and the NNT for PFS is 11 to 23at 1 year. PBT did not benefit patients when used in the first-line setting. In addition, PBT significantly increased the risk of skin toxicity, infections, diarrhea, dehydration, mucositis, hypokalemia, fatigue, hypomagnesemia, pulmonary embolism and paronychia. The NNHs for skin toxicity, diarrhea, infection, hypokalemia and mucositis are less than 23. In conclusion, when used in the subsequent-line setting, PBT can improve the disease progression, especially in mCRC patients with wild-type KRAS. Regarding the adverse events associated with the PBT, close monitoring and necessary preparations are recommended during the therapy.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/mortality , Humans , Panitumumab , Randomized Controlled Trials as Topic , Risk Assessment
2.
Sheng Li Ke Xue Jin Zhan ; 45(5): 385-90, 2014 Oct.
Article in Chinese | MEDLINE | ID: mdl-25764800

ABSTRACT

The dysfunction of vascular system is one of the main causes of orthostatic intolerance induced by microgravity. Vascular endothelial cell is a single layer on the inner wall of the blood vessel and is the important component of the blood vessel wall. Vascular endothelial cell plays a pivotal role in the regulation of vascular functions, such as serving as a permeability barrier, regulating vasoconstriction and vasodilatation. Recent studies have demonstrated that microgravity may have different effects on vascular sys- tem and vascular endothelial cells in different parts of the body, such as increasing vasoconstrictor reactivity and decreasing vasodilator reactivity of cerebral arteries, decreasing vasoconstrictor and vasodilator reactivity of carotid and abdominal aortic arteries, decreasing vasoconstrictor reactivity and increasing vasodilator reactivity of pulmonary arteries, decreasing vasoconstrictor reactivity of mesenteric arteries and veins and lower extremity arteries. In addition, microgravity can promote the growth of vascular endothelial cells in the large vessels and inhibit the growth of microvascular endothelial cells. This paper summarized the research progress in the effects of microgravity on blood vessels and vascular endothelial cells.


Subject(s)
Endothelial Cells , Weightlessness , Mesenteric Arteries , Pulmonary Artery , Vasoconstriction , Vasoconstrictor Agents , Vasodilation , Vasodilator Agents
3.
Fa Yi Xue Za Zhi ; 29(6): 454-7, 2013 Dec.
Article in Chinese | MEDLINE | ID: mdl-24665620

ABSTRACT

As an important component of judicial expertise, forensic science is broad and highly specialized. With development of network technology, increasement of information resources, and improvement of people's legal consciousness, forensic scientists encounter many new problems, and have been required to meet higher evidentiary standards in litigation. In view of this, evidence-based concept should be established in forensic medicine. We should find the most suitable method in forensic science field and other related area to solve specific problems in the evidence-based mode. Evidence-based practice can solve the problems in legal medical field, and it will play a great role in promoting the progress and development of forensic science. This article reviews the basic theory of evidence-based medicine and its effect, way, method, and evaluation in the forensic medicine in order to discuss the application value of forensic evidence-based medicine in computer communication networks.


Subject(s)
Computer Communication Networks , Evidence-Based Medicine , Forensic Medicine , Forensic Sciences , Humans
4.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 41(1): 73-6, 2010 Jan.
Article in Chinese | MEDLINE | ID: mdl-20369474

ABSTRACT

OBJECTIVE: To study the impact of N' N-methylene-bis on thyroglobulin produced by FRTL-5 cells, and to explore the potential of using FRTL-5 cells to screen environmental thyroid hormone disruptors in vitro. METHODS: The FRTL-5 cells were treated with 0.1, 1.0 and 10.0 microg/mL N'N-methylene-bis for 48 hours, respectively. The concentrations of thyroglobulin in the medium of the treated cells were detected by radioimmunoassay. The expression of thyroid peroxidases in the FRTL-5 cells was assessed by enzyme cytochemistry technique. The ultrastructure of the cells was also observed. RESULTS: The FRTL-5 cells treated with 0.1 and 1.0 microg/mL of N' N-methylene-bis produced less thyroglobulin than the controls (P < 0.05). No thyroglobulin was detected with the cells treated with 10.0 microg/mL of N' N-methylene-bis. No difference in the expression of thyroid peroxidases was found between the treated cells and the controls. The treated cells had expanded rough endoplasmic reticulum. CONCLUSION: N' N-methylene-bis disrupts the bio-function of thyroid by damaging the rough endoplasmic reticulum of thyroid follicular cells. FRTL-5 cells can be used for screening thyroid hormone disruptors in vitro.


Subject(s)
Endocrine Disruptors/toxicity , Pesticides/toxicity , Thiadiazoles/toxicity , Thyroglobulin/analysis , Thyroid Gland/drug effects , Animals , Cell Line , Endoplasmic Reticulum, Rough/drug effects , Iodide Peroxidase/analysis , Rats , Thyroid Gland/cytology
5.
Am J Obstet Gynecol ; 201(6): 605.e1-8, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19766982

ABSTRACT

OBJECTIVE: The objective of the study was to assess the association between tea consumption and endometrial cancer. STUDY DESIGN: Studies were identified by searching PubMed and EMBASE databases and screening the references of retrieved articles. The summary relative risk (RR) with 95% confidence interval (CI) was calculated. RESULTS: The combined RR for ever drinkers vs non/lowest drinkers was 0.85 (95% CI, 0.77-0.94). Compared with non/lowest drinkers, the summary RR was 0.88 (95% CI, 0.78-0.98) for low to moderate drinkers and 0.75 (95% CI, 0.64-0.88) for high drinkers. An increase in tea intake of 2 cups/day was associated with a 25% decreased risk of endometrial cancer. In subgroup analyses, tea consumption was significantly associated with reduced endometrial cancer risk in Asian studies and studies using interviewing techniques. Furthermore, the protective effect of green tea on endometrial cancer seemed more evident than that of black tea. CONCLUSION: Findings from this metaanalysis suggest that tea consumption may reduce the risk of endometrial cancer. Because of the limited number of studies, further prospective studies are needed to explore the protective effect of tea on endometrial cancer.


Subject(s)
Beverages , Endometrial Neoplasms/prevention & control , Tea , Case-Control Studies , Cohort Studies , Endometrial Neoplasms/genetics , Female , Humans , Risk Factors
6.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 36(3): 382-5, 2005 May.
Article in Chinese | MEDLINE | ID: mdl-15931875

ABSTRACT

OBJECTIVE: To investigate the adverse effects of perinatal exposure to nonylphenol (NP) on the reproductive development of F1 male SD rats in sexual maturation period. METHODS: The pregnant rats were randomly divided into control, 50 mg/kg, 100 mg/kg, and 200 mg/kg NP groups respectively. NP was administered to dams by gavage from gestation day 7 to weaning period. Rat pups were sacrificed at postnatal day 55. The concentration of serum testosterone was measured by radioimmunoassay. The epididymis was subjected to the determination of sperm count and motility while the testis was submitted to histopathological and immunohistochemical analyses. RESULTS: Compared with control, the concentration of serum testosterone, sperm count and motility in the 200 mg/kg NP dose groups significantly decreased (P < 0.05), and the histopathological examination revealed that NP-treated groups had higher rates of maldeveloped siminiferous tubules, smaller amount of Sertoli cells and weaker spermatogenesis. The expression of proliferative cell nuclear antigen (PCNA) significantly decreased in the 200 mg/kg NP dose groups (P < 0.05). The expression of Arom in 100 mg/kg and 200 mg/kg NP dose groups was lower than that in control. There was no significant difference in ER expression between the control and NP-treated groups. CONCLUSION: These findings indicated that 200 mg/kg Nonylphenol apparently damaged the reproductive development of F1 male SD rats in the sexual maturation period.


Subject(s)
Phenols/toxicity , Sexual Maturation/drug effects , Testosterone/blood , Animals , Female , Male , Pregnancy , Random Allocation , Rats , Rats, Sprague-Dawley , Sperm Count , Sperm Maturation
SELECTION OF CITATIONS
SEARCH DETAIL
...